Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues.
Front Immunol
; 14: 1147960, 2023.
Article
in En
| MEDLINE
| ID: mdl-37359564
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulin G
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: